A massive revenue recovery from a low base has pulled the chemical maker out of deep losses, but profitability is still a fragile 2.4%.
Sadhana Nitro Chem reported a staggering 1221% year-on-year revenue surge to ₹35.67 crore for Q2 FY27, turning a quarterly profit of ₹0.85 crore. The profit margin remains thin at 2.4%, highlighting ongoing cost pressures despite the top-line boom.
For Sadhana Nitro Chem, the September quarter was about escaping a deep hole. After a year of negligible sales and heavy losses, the chemical intermediates maker needed to prove its operations were back on track. The result is a staggering revenue jump that has finally pulled the company into the black, but only by the slimmest of margins.
The numbers tell a story of recovery, but not yet of strength. Revenue soared to ₹35.67 crore, up 1221% from a dismal ₹2.7 crore in the same quarter last year. Sequentially, sales grew 31% from ₹27.22 crore in Q1. This surge delivered a net profit of ₹0.85 crore, a welcome shift from a loss of ₹25.55 crore a year ago. Yet, the net profit margin is a fragile 2.4%.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 | PreviousQ1 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|---|
| Period | Sep 2026 | Jun 2026 | Sep 2025 |
| Revenue (₹ Cr) | 35.67YoY +1221% | 27.22 | 2.70 |
| Profit (₹ Cr) | 0.85YoY +103% | -0.55 | -25.55 |
| Net Profit Margin (%) | 2.4 | -2.0 | – |
The explosive growth is primarily a rebound from an exceptionally weak base. According to reports, the year-ago quarter was crippled by technical production constraints and reduced export demand. The current recovery, while dramatic, is measured against that collapse.
Turning a major revenue increase into meaningful profit has been the challenge. A report from Scanx.trade notes that while revenue expanded massively, total expenses also rose by about 22% year-on-year. This suggests that operational leverage is still limited, with costs keeping pace and capping the bottom line. The company's net profit margin of 2.4% shows how little of the sales surge is converting to earnings.
The path forward hinges on a confirmed order book. The company secured a major two-year, ₹108 crore export contract from a Japanese multinational earlier this year. As noted by Sahi.com, this has boosted Sadhana Nitro's total confirmed order backlog to over ₹200 crore, providing clear revenue visibility for the medium term.
Live Chart
· SADHNANIQ
(BSE)
ISIN: INE888C01040
Executing this backlog requires capital. The balance sheet shows cash has dwindled to just ₹4 lakh as of September, down from ₹11.61 crore in March, pointing to significant working capital needs and ongoing capital expenditure. SectorAlpha.in reports the company has spent ₹115 crore on assets over the last three years, with ₹78 crore of work-in-progress as of FY26, indicating heavy investment in new capacity that is not yet earning.
Key Points
The quarter is a definitive step away from crisis, but not yet a step into robust health. The revenue recovery is real, yet profitability is paper-thin, revealing that the cost structure has not adjusted to support the new sales level. The large order book is the company's strongest asset, promising revenue for at least the next two years.
The critical test is execution. With cash low and capital tied up in unfinished projects, Sadhana Nitro must now demonstrate it can fulfill these orders efficiently. Success would cement the turnaround. Any stumble on costs or delivery, however, could quickly erase the slim profits it has just regained.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.